Cargando…
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
SphK1 is known to play a role in tumor progression, resistance to radiochemotherapy, and migration patterns. As the overall survival rates of squamous cell carcinoma of the head and neck (HNSCC) remain poor due to limitations in surgery and irradiation and chemotherapy resistance, SphK1 is an import...
Autores principales: | Schiefler, Carlotta, Piontek, Guido, Doescher, Johannes, Schuettler, Dominik, Mißlbeck, Martin, Rudelius, Martina, Haug, Anna, Reiter, Rudolf, Brockhoff, Gero, Pickhard, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259444/ https://www.ncbi.nlm.nih.gov/pubmed/25245676 |
Ejemplares similares
-
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021) -
SphK2 over-expression promotes osteosarcoma cell growth
por: Xu, Dawei, et al.
Publicado: (2017) -
Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages
por: Prakash, Hridayesh, et al.
Publicado: (2010) -
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
por: Dai, Lan, et al.
Publicado: (2021)